I can only imagine what will happen to this stock when some network, hopefully CNN highlights the non-surgical technique vs. the one you saw. Safety, combined with price, should make Sunrise the largest player in the field shortly after FDA approval. If they can ship units quickly, this stock is worth a fortune in three years.
Other things happen. Newer technology emerges and we learn how much of this is hype, and how much real. Since there shouldn't be any adverse news for SNRS for a long time, you can trust technical analyst projections about performance, which should be relatively predictible with a combination of stable fundamentals and expected good news.
Rainer has a great grasp of this stock, and he'll only get more accurate.
What we don't know is how much of this $9 is already in anticipation of NASDAQ approval. I suspect, not much but that's a guess.
When it's listed, I hope Rainer will find a sell price, at least for the short term. I would tend to follow his advise this time.
The old philosophy of "buy on the rumor, sell on the news" verified by some solid charting is my guide for SNRS. We should know soon.
Anybody know anthing about ANIK, XOMA, SHMN? Just curious, ANIK has an interesting acid treatment for surgical procedures, that eliminates or reduces the risk of rejection and infection. |
